What are the recommended immediate management steps for a 57-year-old male with heart failure with reduced ejection fraction, a functioning implanted cardioverter‑defibrillator, coronary artery disease, hyperlipidemia, hypertension, who presents with dyspnea and white frothy sputum and a low B‑type natriuretic peptide?

Immediate Management Recommendations

This patient's presentation with dyspnea and white frothy sputum is most likely NOT acute decompensated heart failure given the BNP of 52 pg/mL, which falls well below the diagnostic threshold of 100 pg/mL for acute HF, and you should aggressively pursue alternative diagnoses including acute coronary syndrome, pneumonia, pulmonary embolism, or flash pulmonary edema from acute ischemia. 1

Critical Diagnostic Considerations

The BNP of 52 pg/mL essentially rules out acute decompensated heart failure as the primary etiology. According to the 2022 ACC/AHA/HFSA guidelines, BNP >100 pg/mL (or NT-proBNP >125 pg/mL) is required to support a diagnosis of acute HF 1. This patient's value is less than half the diagnostic threshold.

White Frothy Sputum with Low BNP: Alternative Diagnoses to Pursue

Given the clinical presentation with respiratory distress but low natriuretic peptide, you must immediately evaluate for:

• Acute coronary syndrome with flash pulmonary edema: The patient has known CAD and HFrEF. Acute ischemia can cause rapid-onset pulmonary edema without significant BNP elevation if the presentation is hyperacute. Obtain immediate troponin, ECG, and consider emergent cardiology consultation 2

• Pneumonia or acute respiratory infection: White frothy sputum can occur with severe pneumonia, particularly atypical organisms. Check chest X-ray, complete blood count, and procalcitonin 2

• Pulmonary embolism: Dyspnea with normal BNP in a patient with cardiac disease should raise suspicion. Consider D-dimer if pre-test probability warrants

• Aspiration pneumonitis: Can present with frothy sputum and acute respiratory distress

Immediate Stabilization Protocol

While pursuing diagnostics, implement the following based on European Society of Cardiology acute management guidelines 2:

Monitoring and Support

• Continuous monitoring: Pulse oximetry, blood pressure, respiratory rate, continuous ECG
• Oxygen therapy: Administer if SpO2 <90% or based on clinical judgment for respiratory distress 2
• Non-invasive ventilation: Consider CPAP or BiPAP if respiratory distress is severe 2

Diagnostic Workup (Immediate)

• 12-lead ECG: Essential to exclude ST-elevation MI or acute ischemic changes 2
• Serial troponins: Given CAD history and acute presentation
• Chest X-ray: Rule out pneumonia, pulmonary edema pattern, pneumothorax 2
• Complete metabolic panel: Assess renal function, electrolytes
• Complete blood count: Evaluate for infection
• Arterial blood gas: If severe respiratory distress to assess oxygenation and acid-base status

Therapeutic Considerations

Do NOT empirically treat as acute HF exacerbation given the low BNP. However:

• If blood pressure is elevated and clinical suspicion for flash pulmonary edema from acute ischemia remains high despite low BNP, consider cautious vasodilator therapy (nitroglycerin) while pursuing urgent cardiology evaluation 2

• Diuretics should be withheld until alternative diagnoses are excluded, as the OptiVol is within normal limits and BNP is low, suggesting the patient is not volume overloaded 2

Common Pitfalls to Avoid

1. Do not assume this is HF exacerbation based on history alone: The BNP of 52 pg/mL and normal OptiVol readings strongly argue against volume overload as the primary problem

2. Do not delay evaluation for ACS: In patients with known CAD and HFrEF, acute ischemia can cause rapid pulmonary edema that may present before significant BNP elevation occurs

3. Do not overlook infectious causes: Pneumonia with severe inflammation can produce frothy sputum and mimic cardiogenic pulmonary edema

Risk Stratification

This patient requires immediate triage to a monitored setting (ED resuscitation area, CCU, or ICU) based on respiratory distress criteria 2:

• Respiratory distress with increased work of breathing warrants immediate stabilization and close monitoring
• The presence of white frothy sputum with dyspnea constitutes a potentially life-threatening presentation requiring urgent evaluation

Follow-Up After Stabilization

Once the acute etiology is identified and treated:

• Reassess GDMT optimization for chronic HFrEF management
• Ensure patient is on quadruple therapy (ARNI/ACEi/ARB, beta-blocker, MRA, SGLT2 inhibitor) at target doses 3, 4
• Echocardiography after stabilization to reassess ventricular function and identify any acute changes 2